Slovak
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

lysine/obezita

Odkaz sa uloží do schránky
Strana 1 od 25 výsledky

Comprehensive pharmacologic therapy for treatment of obesity

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side

Comprehensive pharmacologic therapy for treatment of obesity

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
REFERENCES Safer than Phen-Fen (copyright 1997), Written by Michael Anchors, MD Ph.D. Pulmonary Vascular Disease, Medical Clinics of North America Nov. 6. 1997, Written by Donald Heath, MD Ph.D. The "Phen-pro" Diet Drug Combination Is Not Associated with Valvular Heart Disease. Jan. 12, 1998

Comprehensive pharmacologic therapy for treatment of obesity

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
REFERENCES Safer than Phen-Fen (copyright 1997), Written by Michael Anchors, MD Ph.D. Pulmonary Vascular Disease, Medical Clinics of North America Nov. 6, 1997, Written by Donald Heath, MD Ph.D. The "Phen-pro" Diet Drug Combination Is Not Associated with Valvular Heart Disease. Jan. 12, 1998

Comprehensive pharmacologic therapy for treatment of obesity

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side

Comprehensive pharmacologic therapy for treatment of obesity including cysteine

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side

Comprehensive pharmacologic therapy for treatment of obesity including cysteine

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side

Antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
CROSS REFERENCES TO RELATED APPLICATIONS This application claims priority to Japanese Patent Application No. 2004-134683, filed on Apr. 28, 2004. TECHNICAL FIELD OF THE INVENTION The present invention relates to a food for ingestion by an obese person or a person concerned about an increase in body

Abuse resistant lysine amphetamine compounds

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION (i) Field of the Invention The invention relates to amphetamine compounds, compositions and methods of delivery and use comprising amphetamine covalently bound to a chemical moiety. The invention relates to compounds comprised of amphetamine covalently bound to a chemical

Abuse resistant lysine amphetamine compounds

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION (i) Field of the Invention The invention relates to amphetamine compounds, compositions and methods of delivery and use comprising amphetamine covalently bound to a chemical moiety. The invention relates to compounds comprised of amphetamine covalently bound to a chemical

Animal model for type 2 diabetes and obesity

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
PRIORITY This application corresponds to the U.S. national phase of International Application No. PCT/EP2013/072772, filed Oct. 31, 2013, which, in turn, claims priority to European Patent Application No. 12.007446.3 filed Oct. 31, 2012, the contents of which are incorporated by reference herein in

Comprehensive pharmacologic therapy for treatment of a dysfunction

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side

Regulation of protein activity by reversible acetylation

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
FIELD OF THE INVENTION This invention discloses the first cellular acetylated substrate protein of SIRT3, Acetyl-CoA synthetase 2 (AceCS2), which is a mitochondrial matrix protein. The mitochondrial sirtuin SIRT3 interacts with AceCS2 and directly controls the activity of this metabolic enzyme via

Compositions and methods for controlling the weight of animals

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
FIELD OF THE INVENTION This invention relates to compositions and methods for controlling the weight of animals. BACKGROUND OF THE INVENTION Animals, particularly companion animals (e.g., dogs and cats), may weigh more than their ideal body weight. Having an excess of adipose tissue, these animals

Compositions and methods for controlling the weight of animals

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
FIELD OF THE INVENTION This invention relates to compositions and methods for controlling the weight of animals. BACKGROUND OF THE INVENTION Animals, particularly companion animals (e.g., dogs and eats), may weigh more than their ideal body weight. Having an excess of adipose tissue, these animals

Compositions and methods for controlling the weight of animals

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
CROSS REFERENCE TO RELATED APPLICATIONS This application is a US filing under 35 USC 371 of International Application No. PCT/US2007/062710 filed on Feb. 23, 2007, the contents of which are incorporated herein by reference. FIELD OF THE INVENTION This invention relates to compositions and methods
Pripojte sa k našej
facebookovej stránke

Najkompletnejšia databáza liečivých bylín podporovaná vedou

  • Pracuje v 55 jazykoch
  • Bylinné lieky podporené vedou
  • Rozpoznávanie bylín podľa obrázka
  • Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
  • Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
  • Vyhľadajte liečivé byliny podľa ich účinkov
  • Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi

Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume

Google Play badgeApp Store badge